Raj Panjabi: “AI that I see every day at my work at flagship…”

Asserts that the U.S. assessment is that Russia continues offensive biological research.08:27-08:33

Asserts that researchers used AI models to design influenza strains potentially evading vaccines.13:08-13:33

Asserts that there has been one death, 200 contacts observed, and no secondary cases.02:25-02:38

Asserts that pneumonic plague is treatable with common antibiotics if caught early.03:13-03:19

Asserts that if the plague is engineered or drug-resistant, standard treatments may not be effective.03:20-03:29

Asserts that publishing diagnostic results is a crucial step for transparency and safety.03:30-03:38

Asserts that lack of transparency and hospital lockdowns erode public trust.04:58-05:10

Asserts that new cases among close contacts would be a trigger for concern.06:42-06:52

Asserts that listing additional contacts would indicate a need for increased concern.06:52-06:59

Asserts that expanding restrictions would be a trigger for increased concern.06:59-07:08

Asserts that there is currently no evidence suggesting the pathogen is engineered.08:12-08:17

Asserts uncertainty about the facility's current involvement in offensive biological weapons research.08:17-08:26

Asserts that genome sequencing can quickly determine the nature of the pathogen.08:44-08:52

Asserts that AI will complicate and simplify the detection and origin tracing of pathogens.09:54-10:00

Asserts that AI tools beneficial for health can also be misused to create biological weapons.10:19-10:33

Asserts that the AI accord requires companies to implement internal controls for monitoring AI models.11:15-11:31

Asserts that the AI accord includes biosecurity measures and external evaluations.11:31-11:41

Asserts that the AI accord lacks clarity on biosecurity thresholds and decision-making processes.11:56-12:05

Asserts that AI cannot currently create pathogens without human intervention and physical resources.14:13-14:22

Asserts that AI is improving in assisting scientific research in biology.15:11-15:17

Asserts that AI is used in medical advancements such as disease prediction and treatment acceleration.15:16-15:23

Asserts that AI tools could potentially be used for bioterrorism.15:23-15:28

Asserts the need for balancing AI's benefits with minimizing its risks.15:28-15:38

Raj Panjabi: “AI that I see every day at my work at flagship Pioneering, where we create life science companies being used…”